Levothyroxine Dosing in Pregnant Women
For pregnant women already on levothyroxine, increase the dose by 30% (typically two additional tablets per week) immediately upon pregnancy confirmation, then adjust based on TSH monitoring every 4 weeks to maintain trimester-specific TSH targets (first trimester ≤2.5 mIU/L, second/third trimester ≤3.0 mIU/L). 1, 2
Pre-existing Hypothyroidism
For women already taking levothyroxine before pregnancy:
- Immediate action: Increase dose by 30-50% as soon as pregnancy is confirmed (by 4-6 weeks gestation) 1
- Practical approach: Add two extra tablets per week (taking 9 tablets weekly instead of 7) 1
- Dose increment by patient type:
Critical timing: The levothyroxine requirement increases as early as the fifth week of gestation and plateaus by week 16, with a mean 47% increase needed during the first half of pregnancy 3. This early increase is essential because maternal thyroid hormone is critical for fetal neurodevelopment in the first trimester.
New-Onset Hypothyroidism During Pregnancy
When hypothyroidism is first discovered during pregnancy, the FDA-approved dosing and guideline recommendations are 2:
For TSH ≥10 mIU/L (overt hypothyroidism):
- Start at 1.6 mcg/kg/day 2
- Alternative evidence suggests 2.33 mcg/kg/day achieves euthyroidism faster 4
For TSH <10 mIU/L but >2.5 mIU/L (subclinical hypothyroidism):
- Start at 1.0 mcg/kg/day 2
- For TSH 2.5-4.2 mIU/L: 1.20 mcg/kg/day 4
- For TSH 4.2-10 mIU/L: 1.42 mcg/kg/day 4
Alternatively, when TSH is first checked during pregnancy 1:
- TSH 5-10 mIU/L: increase by 25-50 mcg/day
- TSH 10-20 mIU/L: increase by 50-75 mcg/day
- TSH >20 mIU/L: increase by 75-100 mcg/day
For new-onset subclinical hypothyroidism with TSH 2.5-10 mIU/L, starting at 50 mcg/day or more is recommended 1.
Monitoring Strategy
Frequency 2:
- Check TSH and free T4 as soon as pregnancy is confirmed
- Monitor TSH every 4 weeks until stable dose achieved
- Continue monitoring at minimum once per trimester
- Maintain TSH in trimester-specific reference range (first trimester ≤2.5 mIU/L, second/third trimester ≤3.0 mIU/L)
Dose adjustments: Increase levothyroxine by 12.5-25 mcg per day increments until TSH normalizes 2
Post-Delivery Management
Immediately after delivery: Reduce levothyroxine dose back to pre-pregnancy levels 2
Follow-up: Monitor TSH 4-8 weeks postpartum 2
Important Clinical Considerations
Common pitfalls to avoid:
- Waiting too long to increase the dose—the increase should occur by 4-6 weeks gestation, not later in pregnancy
- Using non-pregnancy-specific TSH reference ranges (the upper limit is 2.5 mIU/L in first trimester, not 4.0 mIU/L) 1
- Failing to verify correct levothyroxine administration technique before dose escalation—77.4% of patients take levothyroxine incorrectly, and correcting technique alone can normalize TSH in many cases 5
Administration technique: Levothyroxine must be taken on an empty stomach, 30-60 minutes before breakfast, with water only, to ensure adequate absorption 5
Formulation considerations: Recent evidence suggests nontablet formulations (liquid) may require lower doses (1.5 mcg/kg/day) compared to tablets (2.4 mcg/kg/day) to achieve the same TSH target in non-post-thyroidectomy hypothyroidism 6, though this requires further validation.
Evidence for benefit: High-quality meta-analytic evidence confirms that levothyroxine treatment significantly reduces pregnancy loss (RR=0.43), preterm delivery (RR=0.56), and gestational hypertension (RR=0.63), particularly when initiated early in pregnancy and in women with TSH >4.0 mIU/L 7.